BJDX Logo

Bluejay Diagnostics, Inc. (BJDX) 

NASDAQ
Market Cap
$2.47M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
348 of 794
Rank in Industry
48 of 103

Largest Insider Buys in Sector

BJDX Stock Price History Chart

BJDX Stock Performance

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the …

Insider Activity of Bluejay Diagnostics, Inc.

Over the last 12 months, insiders at Bluejay Diagnostics, Inc. have bought $3,170 and sold $0 worth of Bluejay Diagnostics, Inc. stock.

On average, over the past 5 years, insiders at Bluejay Diagnostics, Inc. have bought $61,573 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Dey Indranil (President and CEO) — $1,635. Dey Svetlana (director) — $1,535.

The last purchase of 500 shares for transaction amount of $1,635 was made by Dey Indranil (President and CEO) on 2023‑12‑13.

List of Insider Buy and Sell Transactions, Bluejay Diagnostics, Inc.

2023-12-13PurchaseDey IndranilPresident and CEO
500
0.044%
$3.27$1,635-79.40%
2023-12-13PurchaseDey Svetlanadirector
500
0.0413%
$3.07$1,535-79.40%
2023-03-28PurchaseDey IndranilPresident and CEO
2,000
0.0105%
$0.44$880-49.65%
2023-03-27PurchaseDey IndranilPresident and CEO
8,000
0.0393%
$0.44$3,520-53.01%
2023-03-24PurchaseDey Svetlanadirector
10,000
0.0502%
$0.44$4,400-51.67%
2022-08-26PurchaseFisher Kenneth RChief Financial Officer
20,000
0.0992%
$1.03$20,600-57.23%
2022-04-25PurchaseFisher Kenneth RChief Financial Officer
20,000
0.0943%
$0.99$19,800-21.74%
2022-03-17PurchaseWurth Douglas Clark
40,000
0.1983%
$1.18$47,120-24.35%
2022-03-17PurchaseKinder Gordon WinstonChief Financial Officer
2,500
0.0122%
$1.16$2,898-24.35%
2022-03-17PurchaseDey Svetlana
10,000
0.0498%
$1.18$11,830-24.35%
2022-03-16PurchaseWurth Douglas Clark
60,000
0.2823%
$1.09$65,400-20.91%
2022-03-14PurchaseKinder Gordon WinstonChief Financial Officer
5,000
0.0274%
$1.02$5,100+1.69%

Insider Historical Profitability

<0.0001%
Dey IndranilPresident and CEO
28526
0.1724%
$0.1530<0.0001%
Dey Svetlanadirector
1500
0.0091%
$0.1530<0.0001%
Wurth Douglas Clark
2286349
13.8164%
$0.1520<0.0001%
Fisher Kenneth RChief Financial Officer
40000
0.2417%
$0.1520<0.0001%
Kinder Gordon WinstonChief Financial Officer
18500
0.1118%
$0.1520<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders